Comparative Pharmacology
Head-to-head clinical analysis: ACTICLATE CAP versus DYNA HEX 4.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTICLATE CAP versus DYNA HEX 4.
ACTICLATE CAP vs DYNA-HEX 4
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking aminoacyl-tRNA binding.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic and disinfectant that disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death.
350 mg orally once daily, increased to 350 mg twice daily if no response after 2 weeks.
1-2 tablets (200-400 mg chlorhexidine gluconate) sublingually every 6 hours as needed for symptom relief.
None Documented
None Documented
Terminal elimination half-life 6-10 hours; prolonged in renal impairment (up to 22 hours in anuria)
Terminal elimination half-life: 2.5-3.5 hours (prolonged in renal impairment).
Renal (60-70% as unchanged drug), fecal (20-30% as metabolites); minor biliary elimination
Renal: 60-80% unchanged; Fecal: 20-40% as metabolites.
Category C
Category C
Tetracycline Antibiotic
Tetracycline Antibiotic